Idea of the Week
Breakouts have become more widespread in the biotech arena, reflected by the SPDR S&P Biotech ETF (XBI) which recently made a new two-year high. Today, we scanned through charts of dozens of biotech stocks in search of a name that has a positive technical catalyst but is not yet overextended in its appearance.
Keep reading with a 7-day free trial
Subscribe to Fairlead Strategies Idea Generator to keep reading this post and get 7 days of free access to the full post archives.